Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03280706
Other study ID # tcc-anele-2017
Secondary ID
Status Completed
Phase N/A
First received September 9, 2017
Last updated February 6, 2018
Start date September 9, 2017
Est. completion date February 2, 2018

Study information

Verified date February 2018
Source Brasilia University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the gastric emptying of pregnant woman at term who received one of the three solutions: maltodextrin, orange juice or coffee with milk.


Description:

Allocation in maltodextrin, orange juice or coffee with milk will be random using sealed envelopes. Gastric ultrasound will be used for estimating gastric volume by measuring antral area in right lateral decubiti. All solutions will have the same volume and total of calories.


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date February 2, 2018
Est. primary completion date February 1, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Pregnancy at term

- Fasted with an emptying stomach (assessed by ultrasound)

- During Labor

- No diabetes, esophageal disease, obesity

- Not emergency

- High risk of need of general anesthesia

Exclusion Criteria:

- Vomiting before the end of the protocol

- Did not drink the whole solutions

- Ultrasound not performed for any reason

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Maltodextrin
Maltodextrin 50g in water 500ml
Orange Juice
Orange juice 480ml + 20ml of water
Coffee with milk
Coffee with milk (330 ml of milk + 220 of water)

Locations

Country Name City State
Brazil University Hospital of Brasilia University Brasilia Distrito Federal

Sponsors (1)

Lead Sponsor Collaborator
Brasilia University Hospital

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Gastric antral area Change from Baseline Gastric antral area measured by ultrasound baseline (before drinking allocated solution), 30, 60, 90 and 120 minutes after drinking.
See also
  Status Clinical Trial Phase
Completed NCT03239821 - Clinical Evaluation of the VIPUN Balloon Catheter 0.1 N/A
Completed NCT00896246 - Scintigraphic Assessment Following Klean-Prep® or Moviprep® Phase 1
Completed NCT03694509 - Gastric Emptying After Tea With Milk in Pregnancy. N/A
Withdrawn NCT03376399 - Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
Completed NCT04092049 - Lollipop on Gastric Emptying N/A
Withdrawn NCT01008371 - Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity. N/A
Completed NCT00940849 - Gastric Emptying and Gallbladder Motility Study N/A
Completed NCT00980083 - GLP-1 - Regulatory Mechanism of Postprandial Glycemia Phase 1
Completed NCT04571866 - Gastric Emptying After Bread Consumption N/A
Active, not recruiting NCT06195488 - Gastric Ultrasound in Diabetic Patients
Recruiting NCT03636828 - Gastric Emptying Time of a Rice-based Meal
Completed NCT04972357 - Bariatric Procedures and Changes Gastric Passage
Completed NCT02587611 - Randomized Comparison of Elemental Liquid Diet and Standard Semi-solid Diet on Gastric Emptying N/A
Completed NCT01809938 - Does Adding Milk to Tea Delay Gastric Emptying? N/A
Completed NCT04263415 - The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity Phase 4
Recruiting NCT05507801 - Protein and Satiety in Older Adults (PROSAT) N/A
Recruiting NCT04623450 - Macronutrients and Satiety in Older and Younger Adults N/A
Recruiting NCT05977244 - Exploring the Effects of Varying Fat:Carbohydrate Diet Permutations on Gastric Emptying and Metabolic Status Using Human Postprandial Model N/A
Completed NCT01133691 - Examination of Gastric Emptying in Children N/A
Completed NCT00276406 - Use of Pyridostigmine for Constipation in Diabetics Phase 1/Phase 2

External Links